- Investing Ideas
- /
- Pharmaceuticals & Biotech ASX High Growth Stocks With High Insider Ownership
Pharmaceuticals & Biotech ASX High Growth Stocks With High Insider Ownership
Results
3
Discover high-potential growth companies backed by strong fundamentals, optimistic outlooks, and high insider ownership.
These stocks show rapid revenue and earnings growth, supported by bullish analyst forecasts and confident guidance from company leadership.
High insider ownership signals management’s belief in the company’s future, aligning their interests with shareholders.
3 companies
EZZ Life Science Holdings
Market Cap: AU$117.0m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.
EZZ
AU$2.48
7D
13.2%
1Y
-50.0%
Clinuvel Pharmaceuticals
Market Cap: AU$625.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$12.48
7D
10.4%
1Y
-11.4%
Medical Developments International
Market Cap: AU$73.8m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.66
7D
-3.7%
1Y
45.6%